U.S., Aug. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07768111) titled 'Clinical Study on Drug Interactions of Flonoltinib Maleate Tablets' on Aug. 05.
Brief Summary: This study is a single center, open label, fixed sequence drug interaction study to evaluate the effects of CYP3A4 inhibitor itraconazole and CYP3A4 inducer rifampicin on the pharmacokinetic characteristics of a single oral dose of flonotinib maleate tablets.
This trial includes screening period, baseline period, medication observation period, and follow-up period, totaling approximately 3 months.
Study Start Date: Oct. 30
Study Type: INTERVENTIONAL
Condition:
Drug Interaction Research
Intervention:
DRUG: 75mg Flonoltinib
Day 1 and...